Journal of Cancer Research and Clinical Oncology

Article	Citations
Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study	174
Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis	106
A case of rare metachronous four primary carcinoma	86
A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection	76
Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection	75
Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience	73
Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cance	67
Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer	60
Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3	59
Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma	57
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma	57
Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: correspondence	56
Can whole-body MRI replace CT in management of metastatic testicular cancer? A prospective, non-inferiority study	55
Expression and clinical prognostic value of CYB561 in breast cancer	55
GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort	50
Introducing a standardized assessment of patients’ interest in and usage of CAM in routine cancer care: chances and risks from patients’ and physicians’ point of view	49
MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study	48
Single-center experience in the diagnosis and treatment of lymphoepithelioma-like hepatic carcinoma	47
Claudins as biomarkers of differential diagnosis and prognosis of tumors	45
Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma	43
Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy	43
Comment on “Predicting metastasis at initial diagnosis and radiotherapy effectiveness in patients with metastatic osteosarcoma”	42
Combination of multiple nucleic acid aptamers for precision detection of tumors based on optical methods	40
Clinical characteristics of sarcoma patients: a population-based data analysis from a German clinical cancer registry	39
Optical coherence tomography and convolutional neural networks can differentiate colorectal liver metastases from liver parenchyma ex vivo	39

Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case rep	39
Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis	38
Breast cancer prediction using different machine learning methods applying multi factors	38
High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients	37
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study	36
Relevance of tumor boards for the inclusion of patients in oncological clinical trials	34
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ	33
Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy	32
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells	30
Comparison of three different methods to detect bone marrow involvement in patients with neuroblastoma	30
Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC	30
Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany	30
Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy	30
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al	29
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors	29
Human papillomavirus (HPV) types 16 and 18 infection and esophageal squamous cell carcinoma: a systematic review and meta-analysis	29
Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies	29
Prognostic nomogram for external ear melanoma patients in the elderly: a SEER-based study	29
Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors	29
The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours	28
Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort study	28
Oral microbiota may predict the presence of esophageal squamous cell carcinoma	28
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients	28
Comparison of robotic‑assisted versus conventional laparoscopic surgery for mid–low rectal cancer: a systematic review and meta-analysis	27
Systematic analysis of mistletoe prescriptions in clinical studies	27
Precision medicine for cancer patients: worth a special issue	26
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma	26
Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma	26
Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas	26
Characterization of tumor microenvironment infiltration and therapeutic responses of cell cycle-related genes’ signature in breast cancer	25
Comparison of intracorporeal and extracorporeal anastomosis in left hemicolectomy: updated meta-analysis of retrospective control trials	25
Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study	25
Incidence profile of four major cancers among migrants in Australia, 2005–2014	25
Global research trends in tumor stem cell-derived exosomes and tumor microenvironment: visualization biology analysis	24
Rare benign liver tumors that require differentiation from hepatocellular carcinoma: focus on diagnosis and treatment	24
Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study	24
DNA methylation-related lncRNAs predict prognosis and immunotherapy response in gastric cancer	23
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology g	23
Decreased expression of prolyl hydroxylase 1 is associated with poor prognosis in colorectal cancers	23
What do hematologists and oncologists consider necessary for their career? Results of an online survey in Germany, Austria and Switzerland	23
Quality of life in Tunisian colorectal cancer patients: a cross-sectional study	23
Development and external validation of a clinical–radiomics nomogram for preoperative prediction of LVSI status in patients with endometrial carcinoma	22
Clinical research progress on BRAF V600E-mutant advanced colorectal cancer	22
Characterization of clinicopathological features, treatment practices, and outcomes among Finnish advanced breast cancer patients in real-life clinical practice	22
Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen	22
95% Confidence intervals or P-values?	22
“I do not hear you!”: hearing-impaired cancer patients report their communication experiences	22
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro	22
Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial	22
D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pediatric rhabdomyosarcoma	22

Two novel clinical tools to predict the risk of bone metastasis and overall survival in esophageal cancer patients: a large population-based retrospective cohort study	21
Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients	21
Emerging markers of cancer cachexia and their relationship to sarcopenia	21
A real-world study of the efficacy and safety of furmonertinib for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations	21
A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials	21
Radiation modulates expression and related activities of c-Met protein in oral tongue squamous cell carcinoma cell lines	21
Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma	21
Single-cell transcriptome highlights a multilayer regulatory network on an invasive trajectory within colorectal cancer progression	20
MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety	20
Integrative analysis of lactylation-related genes and establishment of a novel prognostic signature for hepatocellular carcinoma	20
The roles of FXYD family members in ovarian cancer: an integrated analysis by mining TCGA and GEO databases and functional validations	20
Association of birth weight with cancer risk: a dose–response meta-analysis and Mendelian randomization study	20
Graph neural network-based breast cancer diagnosis using ultrasound images with optimized graph construction integrating the medically significant features	20
Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany	19
BTB protein family and human breast cancer: signaling pathways and clinical progress	19
Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinoma	19
Aberrant expression of cuproptosis‑related gene LIPT1 is associated with metabolic dysregulation of fatty acid and prognosis in hepatocellular carcinoma	19
Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma	19
Histone methyltransferase KMT2C plays an oncogenic role in prostate cancer	19
Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world	19
Hypofractionated versus standard chemoradiotherapy in the definitive treatment of uterine cervix cancer: interim results of a randomized controlled clinical trial	19
Reversing resistance to immune checkpoint inhibitor by adding recombinant human adenovirus type 5 in a patient with small cell lung cancer with promoted immune infiltration: a case report	19
Plasma cell-free DNA as a sensitive biomarker for multi-cancer detection and immunotherapy outcomes prediction	19
Survival benefit and impact of adjuvant therapies following FOLFOX-HAIC-based conversion therapy with unresectable hepatocellular carcinoma: a retrospective cohort study	19
Noninvasive grading of glioma brain tumors using magnetic resonance imaging and deep learning methods	19
NUDT21 interacts with NDUFS2 to activate the PI3K/AKT pathway and promotes pancreatic cancer pathogenesis	19
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives	19
The different clonal origins of metachronous and synchronous metastases	19
Significance of spread through air spaces in small cell lung cancer	18
GUEST EDITORIAL: Theranostics in breast cancer—a vision	18
Prognostic modelling of colorectal cancer based on oxidative stress-related genes	18
Tumor budding as an indicator for lymph node metastasis and prognosis of early gastric cancer	18
Construction and validation of a nomogram for hepatocellular carcinoma patients treated by traditional Chinese medicine based on inflammation, nutrition, and blood lipid indicators	18
Automatic breast cancer diagnosis based on hybrid dimensionality reduction technique and ensemble classification	18
Efficacy of CDK4/6 inhibitors combined with endocrine therapy in HR+/HER2− breast cancer: an umbrella review	18
Reactivation of natural killer cells with monoclonal antibodies in the microenvironment of malignant neoplasms	18
Effect of mindfulness yoga on anxiety and depression in early breast cancer patients received adjuvant chemotherapy: a randomized clinical trial	18
Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating MYC	18
Mental burden and moral distress among oncologists and oncology nurses in Germany during the third wave of the COVID-19 pandemic: a cross-sectional survey	18
A systematic review and meta-analysis of prognostic indicators in patients with head and neck malignancy treated with immune checkpoint inhibitors	18
TKIs beyond immunotherapy predict improved survival in advanced HCC	17
Ten years of AMNOG from an oncological perspective: new horizons and continuing expansion	17
Primary retroperitoneal squamous cell carcinoma: a literature review	17
Real world data on IO-based therapy for metastatic renal cell carcinoma	17
Prognostic value of preoperative microscopic hematuria in patients with non-metastatic renal cell carcinoma who underwent nephrectomy	17
Improvement in colorectal cancer outcomes over time is limited to patients with left-sided disease	17
The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer	17
Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer	17
Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence	17
Predictive biomarkers for immunotherapy response in extensive-stage SCLC	17
Developing prognostic nomograms to predict overall survival and cancer-specific survival in synchronous multiple primary colorectal cancer based on the SEER database	17
Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation	17
Efficacy of rechallenge immunotherapy after immune monotherapy resistance in patients with advanced non-small cell lung cancer	17
Differential diagnosis of lymphoma with 18F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy	17
Establishing a metastasis-related diagnosis and prognosis model for lung adenocarcinoma through CRISPR library and TCGA database	17
Implications for pelvic lymph node irradiation in definitive chemoradiotherapy of node negative muscle invasive bladder cancer based on predictive factors of clinicopathologic discrepancy	17
Investigation of the roles of IL-18 (-607 C/A) and IL-18 (-137 G/C) gene variations in bladder cancer development: case–control study	17
Neferine, a novel ROCK1-targeting inhibitor, blocks EMT process and induces apoptosis in non-small cell lung cancer	16
Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era	16
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis	16
Are sleep disorders associated with the risk of gastrointestinal cancer?—A case–control study	16
METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b	16
Nurses’ knowledge of chemotherapy-induced neutropenia and its management: a cross-sectional survey	16
The correlation between the expression of ubiquitin-conjugating enzyme 2C and prostate cancer prognosis	16
Exploring the correlation between HER2 alterations and 18F-FDG PET/CT metabolic parameters and their prognostic value in EGFR-negative non-small-cell lung cancer patients	16
Clinical characteristics and outcomes of tyrosine kinase inhibitor-related lower GI adverse effects	16
Secular trends and attributable risk factors of esophageal cancer deaths among non-elderly adults based on Global Burden of Disease Study	16
Novel scoring system guiding the incorporation of adjuvant RT for neuroendocrine neoplasms treated with surgical resection followed by chemotherapy	16
PARP inhibitors and overall survival in ovarian cancer, reevaluation advised in all settings	16
Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage	16
Water therapies (hydrotherapy, balneotherapy or aqua therapy) for patients with cancer: a systematic review	16
Construction of noninvasive prognostic model of bladder cancer patients based on urine proteomics and screening of natural compounds	15
Opportunities and challenges in combining immunotherapy and radiotherapy in esophageal cancer	15
Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing	15
SPOCK2 gene expression is downregulated in pancreatic ductal adenocarcinoma cells and correlates with prognosis of patients with pancreatic cancer	15
The disappearance of gastric metastasis and liver metastasis in non-small cell lung adenocarcinoma is due to osimertinib	15
Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis	15
Brown fat activation demonstrated on FDG PET/CT predicts survival outcome	15
Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia	15
Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up	15

Prevalence and severity of anxiety in cancer patients: results from a multi-center cohort study in Germany	15
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study	15
Tumor-derived miRNAs as tumor microenvironment regulators for synergistic therapeutic options	15
GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients	15
A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer	15
Clinical applications of minimally invasive uniportal video-assisted thoracic surgery	15
Association between secondhand smoke and cancers in adults in the US population	15
Crizotinib: aseptic abscesses in multiple organs during treatment of EML4-ALK-positive NSCLC	15
A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif® in healthy Chinese subjects	15
Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment	14
LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway	14
Developing an effective quality evaluation strategy of next-generation sequencing for accurate detecting non-small cell lung cancer samples with variable characteristics: a real-world clinical practic	14
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA	14
Case report: identification of EGFR R776H and FANCE R381H germline mutations in a patient with multiple pulmonary nodules	14
Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia	14
Body composition predicts prognosis of hepatocellular carcinoma patients undergoing immune checkpoint inhibitors	14
The HDAC inhibitor domatinostat induces type I interferon α in Merkel cell carcinoma by HES1 repression	14
Response to letter to the editor regarding C Franzese et al. “Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer”	14
Comparing strategy of immune checkpoint inhibitors plus chemotherapy with chemotherapy alone for small cell lung cancer: a meta-analysis based on six RCTs incorporating 2800 participants	14
Effect of segmental versus marginal mandibular resection on local and lymph node recurrences in oral squamous cell carcinoma: is tumorous bone infiltration or location and resulting soft tissue recurr	14
Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with pros	14
Identification and validation of a plasma metabolomics-based model for risk stratification of intrahepatic cholangiocarcinoma	14
Intratumoral delivery of a Tim-3 antibody-encoding oncolytic adenovirus engages an effective antitumor immune response in liver cancer	14
Does three cycles of neoadjuvant chemotherapy prior to concurrent chemoradiotherapy provide benefits for all childhood patients with locoregionally advanced nasopharyngeal carcinoma?	14
Interactions of occult tumor spread and surgical technique on overall and disease-free survival in patients operated for stage I and II right-sided colon cancer	14
High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system	14
Decoding the role of aberrant RNA alternative splicing in hepatocellular carcinoma: a comprehensive review	14
A novel postoperative nomogram and risk classification system for individualized estimation of survival among patients with parotid gland carcinoma after surgery	14
The value of an apparent diffusion coefficient histogram model in predicting meningioma recurrence	14
Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma	14
Prognosis of different extrathoracic metastasis patterns in patients with M1c lung adenocarcinoma receiving immunotherapy	14
Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers	14
Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study	14
Breast cancer knowledge and practices amongst women in Algeria	14
Differences of genomic alterations and heavy metals in non-small cell lung cancer with different histological subtypes	14
Feasibility study on individualized management of postoperative patients with differentiated thyroid cancer based on internet and programming technology	14
Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone	13
An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma	13
Construction and validation of a SEER-based prognostic nomogram for young and middle-aged males patients with hepatocellular carcinoma	13
Human papillomavirus E7 protein induces homologous recombination defects and PARPi sensitivity	13
Outcomes of immunotherapy-related hepatotoxicity from a multi-disciplinary toxicity team	13
Correlation of several forms of folic acid with endometrial cancer: cross-sectional data from the National Health and Nutrition Examination Surveys (NHANES) 2011–2018	13
Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis	13
Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus	13
Brain metastases of sarcoma: a rare phenomenon in rare tumours	13
The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular ca	13
Development and external validation of a novel nomogram to predict intravesical recurrence after radical nephroureterectomy: a multicenter study	13
Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposure	13
Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms	13
KCMF1 regulates autophagy and ion channels’ function in renal cell carcinoma: a future therapeutic target	13
Oral cancer awareness campaign in Northern Germany: successful steps to raise awareness for early detection	12
Development and validation of a model to predict the risk of distant metastases from hepatocellular carcinoma: a real-world retrospective study	12
Immune-related adverse events after immune checkpoint inhibitor exposure in adult cancer patients with pre-existing autoimmune diseases	12
Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments	12
Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer	12
Targeting adipocyte–immune cell crosstalk to control breast cancer progression	12
What would one of the greatest natural scientists and educators of the eighteenth century, Georg Christoph Lichtenberg, say about the current therapy management of patients with penile cancer?	12
Herpes zoster is not associated with subsequent gastrointestinal cancer: data from over 200,000 outpatients in Germany	12
FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract	12
Hepatic artery intervention combined with immune-targeted therapy is superior to sequential therapy in BCLC-C hepatocellular carcinoma	12
CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate	12
Advances in the application of computational pathology in diagnosis, immunomicroenvironment recognition, and immunotherapy evaluation of breast cancer: a narrative review	12
The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma	12
Expression profiling of luminal B breast tumor in Indian women	12
Classification of the immune microenvironment associated with 12 cell death modes and construction of a prognostic model for squamous cell lung cancer	12
ShallowHRD status acts as an effective prognostic predictor in ovarian cancer patients treated by poly (ADP-ribose) polymerase inhibitors (PARPis)	12
A competing risk nomogram to predict cancer-specific mortality of patients with late-onset colorectal cancer	12
Current trends of targeted therapy for oral squamous cell carcinoma	12
Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer	12
Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age—a statistical analysis	12
Using deep learning to predict survival outcome in non-surgical cervical cancer patients based on pathological images	12
Competing endogenous RNA network characterization of lymph node metastases in Leuran gastric cancer subtypes	12
Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients	12
The positive feedback loop of MAD2L1/TYK2/STAT3 induces progression in B-cell acute lymphoblastic leukaemia	12
Spontaneous histological transformation of lung squamous-cell carcinoma to large cell neuroendocrine carcinoma and small cell lung cancer	12
Efficacy of superselective neck dissection (IIA and III) for supraglottic laryngeal cancer with clinically negative neck	11
Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center	11
Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis	11
miR-9-5p expression is associated with vascular invasion and prognosis in hepatocellular carcinoma, and in vitro verification	11
The relationship of airflow limitation with lung squamous cell carcinoma: evidence from mendelian randomization analysis	11
Resilience in cancer patients and how it correlates with demographics, psychological factors, and lifestyle	11
Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG)	11
Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing	11
Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response	11
MTA1 as negative prognostic marker in vulvar carcinoma	11
ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study	11
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017	11
Construction and validation of stemness-related lncRNA pair signature for predicting prognosis in colorectal cancer	11
The role of potassium in depth profiling of the tumor border in bone-invasive oral cancer using laser-induced breakdown spectroscopy (LIBS): a pilot study	11
Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia	11
Network meta-analysis of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment	11
Causal relationship between lung diseases and risk of esophageal cancer: insights from Mendelian randomization	11
Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer	11
Targeting the undruggable: menin inhibitors ante portas	11
The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer	11